Wohl A J, Laborde N J, Atkins J M, Blomqvist C G, Mullins C B
Arch Intern Med. 1976 Apr;136(4):406-8.
In 39 patients (mean age, 66 years) treated for sick sinus syndrome (SSS) with pacemaker insertion, the long-term prognosis was studied. Fifteen patients (42%) died during the follow-up period of 6 to 59 months (mean, 25 months). Three patients were unavailable for follow-up. Eleven of the 15 deaths (73%) were cardiac-related, yet none could be associated with either an arrhythmia or pacemaker failure. Symptoms recurred or persisted after pacemaker insertion in 14 patients (mean age, 71 years), nine of whom died (31 deaths per 100 patient follow-up years). Twenty-two patients (mean age, 63 years) were asymptomatic after pacer insertion, six of whom died (11 deaths per 100 patient follow-up years). These follow-up results demonstrate a poor long-term prognosis in patients with SSS and persistent symptoms following permanent pacing.
在39例接受起搏器植入治疗病态窦房结综合征(SSS)的患者(平均年龄66岁)中,对其长期预后进行了研究。15例患者(42%)在6至59个月(平均25个月)的随访期内死亡。3例患者无法进行随访。15例死亡患者中有11例(73%)与心脏相关,但均与心律失常或起搏器故障无关。14例患者(平均年龄71岁)在起搏器植入后症状复发或持续存在,其中9例死亡(每100患者随访年有31例死亡)。22例患者(平均年龄63岁)在起搏器植入后无症状,其中6例死亡(每100患者随访年有11例死亡)。这些随访结果表明,SSS患者以及永久性起搏后仍有持续症状的患者长期预后较差。